Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

60.0%

% of BBH's 27 holdings also in XBI

11.3%

% of XBI's 134 holdings also in BBH

Overlap by Weight
Sector Drift (BBH minus XBI)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBH
Weight
in XBI
Overlap
NEUROCRINE BIOSCIENCES INC 2.8% 2.8% 2.8%
ALNYLAM PHARMACEUTICALS INC 4.1% 2.5% 2.5%
NATERA INC 4.7% 2.5% 2.5%
GILEAD SCIENCES INC 11.7% 2.5% 2.5%
AMGEN INC 16.1% 2.4% 2.4%

Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to XBI
AMGEN INC 13.7%
GILEAD SCIENCES INC 9.3%
VERTEX PHARMACEUTICALS INC 9.0%
ARGENX SE ADR 5.4%
IQVIA HOLDINGS INC 4.5%
ILLUMINA INC 3.9%
REGENERON PHARMACEUTICALS 3.9%
ICON PLC 3.3%
BIONTECH SE SPONSORED ADR 2.7%
NATERA INC 2.3%
BBH Underweight Relative to XBI
ABBVIE INC -2.5%
VAXCYTE, INC. -2.3%
UNITED THERAPEUTICS CORP -2.3%
HALOZYME THERAPEUTICS INC -2.1%
MADRIGAL PHARMACEUTICALS, INC. -1.9%
TG THERAPEUTICS INC -1.8%
BLUEPRINT MEDICINES CORP. -1.7%
VIKING THERAPEUTICS, INC. -1.5%
BRIDGEBIO PHARMA, INC. -1.5%
ADMA BIOLOGICS, INC. -1.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY